Anebulo Pharmaceuticals, Inc.

Anebulo Pharmaceuticals, Inc. financial statements

Anebulo Pharmaceuticals, Inc.'s income statement, balance sheet and cash flow, annual and quarterly, each figure dated and linked to the filing it was read from.

FY2025

RevenueUSD 0EODHD
Net income−USD 8.48M10-K
Cash and equivalentsUSD 11.63M10-Q

Anebulo Pharmaceuticals, Inc. financials on 6ix · Anebulo Pharmaceuticals, Inc. on 6ix